Приказ основних података о документу
Safety and ethical consideration of AIDS vaccine
dc.creator | Veljković, Veljko | |
dc.creator | Prljić, Jelena | |
dc.creator | Veljković, Tatjana | |
dc.date.accessioned | 2018-03-01T19:31:19Z | |
dc.date.available | 2018-03-01T19:31:19Z | |
dc.date.issued | 2004 | |
dc.identifier.issn | 0883-0185 | |
dc.identifier.uri | https://vinar.vin.bg.ac.rs/handle/123456789/2809 | |
dc.description.abstract | It has been demonstrated that HIV-1 gp120 resembles several important properties of immunoglobulins allowing it strong influence on the human immune system, especially through induction of the deceptive imprinting and deregulation of the immune network. On the other hand there are many unanswered questions concerning properties and control of the genetically modified viruses and bacteria used as vectors in AIDS vaccines. This situation opens a serious question about the safety of vectored AIDS vaccine and the ethics of their trials in humans. | en |
dc.rights | restrictedAccess | en |
dc.source | International Reviews of Immunology | en |
dc.subject | HIV-1 gp120 | en |
dc.subject | vectored AIDS vaccines | en |
dc.subject | safety | en |
dc.subject | clinical trial | en |
dc.title | Safety and ethical consideration of AIDS vaccine | en |
dc.type | article | en |
dc.rights.license | ARR | |
dcterms.abstract | Вељковиц, Т; Прљиц, Ј; Вељковић Вељко; | |
dc.citation.volume | 23 | |
dc.citation.issue | 5-6 | |
dc.citation.spage | 465 | |
dc.citation.epage | 486 | |
dc.identifier.wos | 000223983900009 | |
dc.identifier.doi | 10.1080/08830180490432866 | |
dc.identifier.pmid | 15370278 | |
dc.type.version | publishedVersion | |
dc.identifier.scopus | 2-s2.0-4644326954 |
Документи
Датотеке | Величина | Формат | Преглед |
---|---|---|---|
Уз овај запис нема датотека. |